ID   BWZ.36
AC   CVCL_RW63
DR   BTO; BTO_0006294
DR   Wikidata; Q54798741
RX   PubMed=8186188;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Transfected with the NFAT-lacZ construct containing the lacZ reporter gene under control of the NFAT response element.
CC   Characteristics: Does not express functional TCR alpha and beta chains (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_RW62 ! BW-1100.129.237
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
RX   PubMed=8186188; DOI=10.1093/intimm/6.3.369;
RA   Sanderson S., Shastri N.;
RT   "LacZ inducible, antigen/MHC-specific T cell hybrids.";
RL   Int. Immunol. 6:369-376(1994).
//